(TCRαβ+) Double-Negative T Cells in Type 1 Diabetes Mellitus
Poddighe D. Mussayeva A. Dossybayeva K. Zhubanova G. Galiyeva D. Le K.L. Tanko M.N.
January 2026Multidisciplinary Digital Publishing Institute (MDPI)
Cells
2026#15Issue 1
Highlights: What are the main findings? In murine autoimmune diabetes, TCRαβ+DNT cells appear to exert a predominantly protective role against immune-mediated β-cell injury. Very few studies have examined TCRαβ+DNT cells in patients with Type 1 Diabetes Mellitus (T1DM). What are the implication s of the main finding s? TCRαβ+DNT cells might represent an additional therapeutic target in T1DM and other autoimmune conditions. Specific clinical and translational research is needed to better elucidate the role of TCRαβ+DNT cells in T1DM. Type 1 Diabetes Mellitus (T1DM) is an autoimmune disease characterized by the destruction of pancreatic β-cells. Both lymphocytes and various innate immune cells contribute to its immunopathogenesis. Among lymphocytes, in addition to CD8+ T cells, CD4+ T cells, and B cells, growing attention has been directed toward some unconventional T-cell subsets, such as TCRαβ+ double-negative T (DNT) cells, based on findings in several autoimmune/rheumatic diseases. This narrative review aims to summarize and analyze the available data on the potential role of DNT cells (and, in detail, the TCRαβ+ subset) in the immunopathogenesis of autoimmune diabetes/T1DM. Most of the current knowledge regarding DNT cell homeostasis in this pathological setting derives from experimental models, especially Non-Obese Diabetic (NOD) mice. In murine autoimmune diabetes, TCRαβ+DNT cells appear to exert a predominantly protective role against immune-mediated β-cell injury. These cells can be observed in multiple anatomical sites, including the thymus, peripheral blood, secondary lymphoid organs (spleen and lymph nodes) and, under pathological conditions, in non-lymphoid organs, like within the pancreas and, in detail, pancreatic islets, in the setting of autoimmune diabetes. Experimental evidence suggests that TCRαβ+DNT cells may attenuate the CD8+ T cell-mediated destruction of pancreatic β-cells, both directly and indirectly, through the inhibition of CD4+ T cells and B cells implicated in this immunopathological process. Unfortunately, very few studies have examined TCRαβ+DNT cells in patients with T1DM. This important knowledge gap highlights the need for dedicated clinical and translational research to better elucidate the role of TCRαβ+DNT cells in T1DM, especially given the preliminary findings pointing toward their potential immunoregulatory relevance.
autoimmune diabetes , CD4−CD8− T cells , diabetes mellitus type 1 , DN T cells , DNT cells , double negative T cells , NKT cells , NOD mice
Text of the article Перейти на текст статьи
College of Health Sciences, VinUniversity, Vinhomes Ocean Park, Gia Lam, Hanoi, 100000, Viet Nam
School of Medicine, Nazarbayev University, Astana, 010000, Kazakhstan
College of Health Sciences
School of Medicine
10 лет помогаем публиковать статьи Международный издатель
Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026